5-((1,3-Diphenyl-1H-pyrazol-4-yl)methylene)-3-((tetrahydrofuran-2-yl)methyl)-2-thioxothiazolidin-4-one

Catalog No. :
ACYQDX056
CAS No. :
623940-40-9
Molecular Formula :
C24H21N3O2S2
Molecular Weight :
447.58

IUPAC Name:(Z)-5-((1,3-diphenyl-1H-pyrazol-4-yl)methylene)-3-((tetrahydrofuran-2-yl)methyl)-2-thioxothiazolidin-4-one

5-((1,3-Diphenyl-1H-pyrazol-4-yl)methylene)-3-((tetrahydrofuran-2-yl)methyl)-2-thioxothiazolidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-((1,3-Diphenyl-1H-pyrazol-4-yl)methylene)-3-((tetrahydrofuran-2-yl)methyl)-2-thioxothiazolidin-4-one
IUPAC Name(Z)-5-((1,3-diphenyl-1H-pyrazol-4-yl)methylene)-3-((tetrahydrofuran-2-yl)methyl)-2-thioxothiazolidin-4-one
MDL No.MFCD04441513
Molecular FormulaC24H21N3O2S2
Molecular Weight447.58
SMILESO=C1N(CC2OCCC2)C(S/C1=C\C3=CN(C4=CC=CC=C4)N=C3C5=CC=CC=C5)=S
InChI KeyRCZRGXKCCQVRPR-STZFKDTASA-N
SynonymSALOR-INT L440892-1EA;(5Z)-5-[(1,3-DIPHENYL-1H-PYRAZOL-4-YL)METHYLENE]-3-(TETRAHYDRO-2-FURANYLMETHYL)-2-THIOXO-1,3-THIAZOLIDIN-4-ONE;4-Thiazolidinone, 5-[(1,3-diphenyl-1H-pyrazol-4-yl)methylene]-3-[(tetrahydro-2-furanyl)methyl]-2-thioxo-
CAS No.623940-40-9

Synthetic Route by SureRoute

1. ACYQDX056 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCJQO567 route compound structure diagram
    ACCJQO56721487-45-6 In Stock
  4. Then
  5. ACYQDX056 route product structure diagram
    ACYQDX056623940-40-9
Inquiry

2. ACYQDX056 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYQDX056 route product structure diagram
    ACYQDX056623940-40-9
Inquiry

Comments (0)